A newly developed molecule brings together two powerful immunotherapy strategies in one treatment. Researchers at the University of Basel and...

Treating the brain cancer glioblastoma (GBM) demands more than conventional strategies due to a mix of factors including the cancer’s genetic...

Treating the brain cancer glioblastoma (GBM) demands more than conventional strategies due to a mix of factors including the cancer’s genetic...

Cancer treatment resistance, a significant challenge, arises when cancer cells adapt to therapy through genetic mutations, drug expulsion, or...

CAR T cells are patient-derived, genetically engineered immune cells. They are “living drugs” and constitute a milestone in modern medicine....

In a new study that combines synthetic biology with cancer immunotherapy, researchers from the Yong Loo Lin School of Medicine, National University of...

Fusobacterium nucleatum (F.nucleatum) is an anaerobic bacterium notably enriched in the gut microbiota of colorectal cancer (CRC) patients and may...

Fusobacterium nucleatum (F.nucleatum) is an anaerobic bacterium notably enriched in the gut microbiota of colorectal cancer (CRC) patients and may...

Scientists have developed a genetic "Trojan horse" therapy that targets and kills cancer cells tied to Kaposi's sarcoma, with fewer side effects.

CAR T cells are patient-derived, genetically engineered immune cells. They are "living drugs" and constitute a milestone in modern medicine. Equipping...